Sanofi reaping rewards of Emerging Markets focus
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Having concentrated resources in a number of “key” countries including Brazil, Mexico and Russia, Sanofi Consumer Healthcare is enjoying a “strong” growth trajectory in its Emerging Markets, the French pharmaceuticals giant told OTC bulletin.
You may also be interested in...
Q4 Consumer Health Earnings Preview: GSK, Bayer, RB, And Sanofi
GSK is looking to close out 2018 strongly as it prepares to launch its Consumer Health JV with Pfizer, while Bayer will be glad to see the back of a tough year. Elsewhere, RB is preparing for life after Rakesh Kapoor and Sanofi is ramping up its push into digital health.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.